| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 66,812 | 76,421 | 48,910 | | Cost of Revenue | 34,168 | 40,615 | 25,827 | | | Gross Profit | 32,644 | 35,806 | 23,083 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 17,497 | 17,425 | 14,970 | | Non Recurring | (580) |
-
|
-
| | Others | 4,249 | 1,936 | 1,558 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 11,478 | 16,445 | 6,555 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 958 | 690 | 1,053 | | Earnings Before Interest And Taxes | 12,436 | 17,135 | 7,608 | | Interest Expense | 281 | 208 | 151 | | Income Before Tax | 12,155 | 16,927 | 7,457 | | Income Tax Expense | 3,090 | 5,488 | (1,828) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,065 | 11,439 | 9,285 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 9,065 | 11,439 | 9,285 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,065 | $11,439 | $9,285 |
|
1.52% Nasdaq 0.00%
Income Statement
